Ina-Respond: Clinical Trials

1 trial sponsored by Ina-Respond, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Ina-Respond: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
Favipiravir, Azithromycin - Infectious Disease, SARS-CoV Infection
Phase 3CompletedIna-Respond1302020-10-152023-03-08

Conditions studied

COVID-19 (1)  ·  Communicable Diseases (1)  ·  Severe Acute Respiratory Syndrome (1)

Interventions

Azithromycin (1)  ·  favipiravir (1)

Countries

Indonesia (1)